Johnson & Johnson single-shot COVID-19 vaccine appears 66% effective overall in global trial January 29, 2021 Johnson & Johnson's long-awaited vaccine appears to protect against COVID-19 with just one shot. It's not as strong as some of its two-shot rivals but still potentially helpful for a world in dire need of more doses. Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment
Click to see the code!
To insert emoticon you must added at least one space before the code.